08.10.24 -- Bioprocess Online Best Of July

ADCs were yesterday’s news until Daiichi Sankyo’s ENHURTU reanimated the space.

This article demystifies the manufacture of mRNA encapsulated in lipid nanoparticles across unit operations for plasmid linearization, drug substance manufacture, and drug product manufacture.

Mark Petrich, VP of Technical Operations, Krystal Biotech, and single-use consultant and guru Paul Priebe take audience questions on connectors and industry standards.

Dr. Kris Tyner, a subject matter expert in bioprocessing, shares his experience and thoughts on simplifying bioprocessing, gathering answers faster, and de-risking while scaling up.

Explore six trends and risks that are currently paving the way to the future of biopharmaceutical manufacturing.

To aid in the manufacturing of new vaccines, Pichia pastoris yeast, a promising protein expression system, could be the perfect solution.